Premier Path Wealth Partners, LLC Bristol Myers Squibb CO Transaction History
Premier Path Wealth Partners, LLC
- $587 Billion
- Q2 2024
A detailed history of Premier Path Wealth Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 28,617 shares of BMY stock, worth $1.43 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
28,617
Previous 3,757
661.7%
Holding current value
$1.43 Million
Previous $204 Million
483.34%
% of portfolio
0.2%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,399Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.29 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.9 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.55 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.72 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.94 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...